News
Everywhen, formerly Ardonagh Advisory and one of the world’s leading independent insurance brokers, is collaborating with Apogee Corporation, the managed workplace services (MWS) provider, to ...
Apogee Therapeutics said its atopic dermatitis candidate has the potential to offer a more convenient alternative to Sanofi/Regeneron’s Dupixent or Eli Lilly’s Egblyss. Cogent Biosciences reported ...
Review quarterly and annual revenue, net income, and cash flow for Apogee Therapeutics Inc (APGE:XNAS) stock through the last fiscal year.
Review the current Apogee Enterprises Inc (APOG:XNAS) growth, profitability and efficiency, financial health, and cash flow key metrics to decide if APOG is the best investment for you.
View the latest Apogee Therapeutics Inc. (APGE) stock price, news, historical charts, analyst ratings and financial information from WSJ.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results